Stocktoria
COMPASS Pathways plc CMPS
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-09-18
Chart by TradingView
1/9
Piotroski F — financial health
-20.44
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$179.0M | -$178.2M | -$136.9M | -$110.4M | -$83.2M |
| Net income | -$287.9M | -$155.1M | -$118.5M | -$91.5M | -$71.7M |
| Operating cash flow | -$157.2M | -$119.2M | -$97.4M | -$105.5M | -$67.7M |
| Free cash flow | — | -$119.2M | -$97.4M | -$106.0M | -$68.1M |
| Total assets | $210.3M | $213.7M | $276.0M | $197.3M | $300.9M |
| Total liabilities | $263.2M | $59.0M | $50.2M | $16.0M | $16.5M |
| Shareholders' equity | -$52.8M | $154.7M | $225.7M | $181.3M | $284.4M |
| Ratios | |||||
| Return on assets | -136.8% | -72.6% | -42.9% | -46.4% | -23.8% |
| Return on equity | 544.7% | -100.3% | -52.5% | -50.5% | -25.2% |
| Debt / equity | -0.60× | 0.19× | 0.13× | 0.00× | — |
| Current ratio | 0.77 | 5.92 | 13.33 | 12.29 | 19.55 |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| ARK Investment Management LLC | 3,301,050 | $18.3M |
| RENAISSANCE TECHNOLOGIES LLC | 865,354 | $4.8M |
| Point72 Asset Management, L.P. | 23,600 | $130,508 |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -20.44 (distress)
- Working capital / assets -0.268
- Retained earnings / assets -3.911
- EBIT / assets -0.851
- Equity / liabilities -0.201
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001816590 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.